Acute Flaccid Paralysis

Generalities on Poliovirus
Agent	Virus: poliovirus (genus enterovirus), with 3 serotypes: 1, 2 and 3
Incubation period	7-14 days (3-35 days)
Period of transmissibility	7-10 days before onset, up to 3-6 weeks after onset
Reservoir	Humans
Modes of transmission	-Person-to-person: faecal-oral route, and rarely pharyngeal -Rarely through water and food
Clinical presentation	-90-95% asymptomatic infection -4-8% mild illness (influenza-like illness or gastro-intestinal illness) -1-2% aseptic meningitis -<1% paralytic poliomyeltis
Resources
Case definition	- MOPH circular no 34 (2012) - MOPH circular no 76 (2006)
Forms	- General reporting form - Specific reporting form - Investigation form: data collection - Investigation form: additional data - Investigation form: specimen collection - Investigation form: Rapid OPV3/IPV3 coverage survey - Investigation form: Follow up at day 60 - Investigation form: Final classification
Guidelines	Acute Flaccid Paralysis surveillance guideline: Ar, En, Fr
Data	- AFP surveillance bulletin

All

ATC	Name	B/G	Ingredients	Dosage	Form ↑	Price
A07AX03	FUROXYL	G	Nifuroxazide - 200mg	200mg	Capsule	366,037 L.L
J05AH02	FLUMIVIR	G	Oseltamivir - 75mg	75mg	Capsule	1,384,158 L.L
B03AB02	FERRICURE	B	Iron (polysaccharide complex) - 150mg	150mg	Capsule	1,001,163 L.L
J01CR50	FLUMOX	G	Flucloxacillin (monohydrate) - 250mg, Amoxicillin (trihydrate) - 250mg		Capsule	348,055 L.L
C10AB05	FENOSUP LIDOSE	G	Fenofibrate - 160mg	160mg	Capsule	774,053 L.L
C10AB05	FINACOR	G	Fenofibrate micronised - 160mg	160mg	Capsule	774,309 L.L
A03CA02	FLUDINIUM	G	Clidinium bromide - 2.5mg, Trifluoperazine HCl - 1mg		Capsule	386,515 L.L
N06AB03	FLUOXETINA-Key	G	Fluoxetine (HCl) - 20mg	20mg	Capsule	448,843 L.L
N06AB03	FLUOXETINE BIOGARAN	G	Fluoxetine (HCl) - 20mg	20mg	Capsule	239,204 L.L
N06AB03	FULSAC	G	Fluoxetine (HCl) - 20mg	20mg	Capsule	435,405 L.L
N06AB03	FLUTIN	G	Fluoxetine (HCl) - 20mg	20mg	Capsule	362,837 L.L
J01DD08	FIXIM	G	Cefixime (trihydrate) - 200mg	200mg	Capsule	890,968 L.L
J02AC01	FLUNAZOL	G	Fluconazole - 50mg	50mg	Capsule	534,465 L.L
J02AC01	FUNZOL 50	G	Fluconazole - 50mg	50mg	Capsule	373,588 L.L
J01DD08	FIXIM	G	Cefixime (trihydrate) - 400mg	400mg	Capsule	1,435,224 L.L
J02AC01	FAZOL 150	G	Fluconazole - 150mg	150mg	Capsule	623,468 L.L
J02AC01	FLOCAZOLE	G	Fluconazole - 150mg	150mg	Capsule	172,012 L.L
J02AC01	FLUCOKEY	G	Fluconazole - 150mg	150mg	Capsule	103,476 L.L
J02AC01	FLUKAS	G	Fluconazole - 150mg	150mg	Capsule	147,823 L.L
J02AC01	FLUNAZOL	G	Fluconazole - 150mg	150mg	Capsule	149,742 L.L
J02AC01	FUNGIMID 150	G	Fluconazole - 150mg	150mg	Capsule	172,012 L.L
J02AC01	FUNZOL 150	G	Fluconazole - 150mg	150mg	Capsule	170,668 L.L
J02AC02	FONGINOX	G	Itraconazole - 100mg	100mg	Capsule	778,149 L.L
J02AC02	FONGINOX	G	Itraconazole - 100mg	100mg	Capsule	174,060 L.L
C01BC04	FLECAINIDE BIOGARAN L.P.	G	Flecainide acetate - 100mg	100mg	Capsule, extended release	1,154,361 L.L
C01BC04	FLECAINIDE BIOGARAN L.P.	G	Flecainide acetate - 50mg	50mg	Capsule, extended release	1,154,361 L.L
L04AA27	FINGOLIMOD ZENTIVA	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule, hard	32,406,715 L.L
J02AC01	FLUORES	G	Fluconazole - 150mg	150mg	Capsule, hard	428,686 L.L
R03AK06	FLUDALT DUO	G	Salmeterol (xinafoate) - 50mcg, Fluticasone propionate - 100mcg		Capsule, inhalation	1,777,706 L.L
R03AK06	FLUDALT DUO	G	Salmeterol (xinafoate) - 50mcg, Fluticasone propionate - 250mcg		Capsule, inhalation	2,487,891 L.L